[ad_1] Johnson & Johnson products on a shelf in a store in New York. Lucas Jackson | Reuters Johnson & Johnson’s consumer health business Kenvue priced its IPO at $22 per share Wednesday, toward the high end of its stated range, in an upsized deal that would bring in about $3.8 billion. At that IPO price, the new company…
[ad_1] Johnson & Johnson (JNJ) before-the-bell Tuesday reported a strong first quarter, with sales up more than 5.5% and earnings eking out an annual increase. Shares of the Dow component and Club holding should not be losing 2.5% on these kinds of results. J & J’s first-quarter sales of $24.75 billion exceeded the Refinitv consensus…
[ad_1] Wall Street on Tuesday upgraded two underperforming Club stocks — Emerson Electric (EMR) and Danaher (DHR) — to the equivalent of buy ratings. Meanwhile, longtime core holding Apple (AAPL) took another step forward in a key global smartphone market. EMR YTD mountain Emerson Electric’s year-to-date stock performance. The news: Wolfe Research on Tuesday upgraded…
[ad_1] Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Dow drops with earnings in focus J & J decline misguided Starbucks undervalued? 1. Dow drops with earnings in focus Stocks fell Tuesday as Dow stocks Goldman Sachs (GS)…
